Bio-Rad Laboratories

Improving lives with every test.

Chlamydia
DFA and EIA
I N F E C T I O U S

Sexually transmitted diseases (STDs) are recognized as

Direct Fluorescent Antigen Test

a significant worldwide public health problem. Transmission

Uses a fluorescein-conjugated monoclonal antibody

of STDs requires intimate contact and males have higher

transmission rates than females. Although a diverse group

to identify C. trachomatis antigens in direct

clinical specimens

of pathogens can cause STDs, the most common are

Detects all 15 serovars

urogenital infections caused by Chlamydia trachomatis.

Simple, proven and reliable

Results within 15 minutes

D I S E A S E

Pathfinder Chlamydia DFA

(Immunofluorescence)
This direct fluorescent assays kit uses a direct immunofluorescence technique to provide clear, easy-to-read
and reliable results within 15 minutes. Chlamydia
antigens are detected using a monoclonal antibody to

Culture Confirmation Test

A direct fluorescent procedure for the identification
of Chlamydia in cell culture
Uses a genus-specific monoclonal antibodydetects
all 15 serovars
Simple, sensitive and specific

T E S T I N G

the C. trachomatis major outer membrane protein (MOMP)

Chlamydia DFA Specimen Collection Kit

that has been linked to fluorescein isothiocyanate.

Specimen collection kit for DFA testing

The Pathfinder Chlamydia Culture Confirmation provides

Assure critical first step in testing

clear and reliable staining of intracellular inclusions

Chlamydia EIA Specimen Collection Kits

(elementary bodies and reticulate bodies) in tissue culture.

The only universal swab for both males and females

The monoclonal antibody used in this kit is directed against

Brush kits also available

the Chlamydia lipopolysaccharide.

 >

INFECTIOUS DISEASE TESTING

Chlamydia DFA and EIA Testing

Ordering Information

Pathfinder Chlamydia
Microplate (EIA Microplate)

Catalog No.

This EIA microplate opens new perspectives in the direct

30704

detection of Chlamydia. The choice of microplate immunoenzymatic technology and the use of a monoclonal antibody
result in a combination of convenience and performance.

Description

Chlamydia DFA
Pathfinder Chlamydia DFA
(Complete kit with controls) . . . . . . . . 50 detections
30702

Chlamydia trachomatis DFA

(Monoclonal Ab) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.2 mL

Chlamydia Testing Confidence

30705

Chlamydia DFA Control Slide . . . . . . . . . . . . . . . . . . . 1 unit

Objective results for any size lab

30701

Pathfinder Chlamydia Culture

Shortened EIA Procedure to Culture (Resolved)

90.68% sensitivity*
99.93% specificity*
Standard EIA Procedure to Culture (Resolved)
89.44% sensitivity*
99.85% specificity*
Capture monoclonal antibodies increase specificity
and minimize cross reactions often seen in other
chlamydia products
Designed for Value and Productivity
Provides rapid, easy and high-value chlamydia testing
Microwell strip format
Friendly, flexible EIA procedures

Confirmation System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.2 mL

30693

Pathfinder Mounting Medium . . . . . . . . . . . . 2.75 mL

30706

Chlamydia DFA Collection Kit . . . . . . . . . . . . Set of 20

30707

Chlamydia Collection Slides . . . . . . . . . . . . . . . . 90 slides

Chlamydia EIA
31189

Pathfinder Chlamydia Microplate

EIA Kit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 192 tests

34407

Chlamydia Swab Collection Kit . . . . . . 100 pieces

34408

Chlamydia Brush Collection Kit . . . . . . 100 pieces

These complete Chlamydia Systems are configured with the

same assay features, reliability and value available in other
Bio-Rad products.

Shortened assay with incubator-shaker provides results

in less than 2.5 hours making same-day screening and
confirmation possible
Standard 3.5 hour assay at room temperature
Easily incorporated into the laboratory workflow
* Note: The resolved sensitivities and specificities listed above reflect
the discrepant resolution of samples that were EIA positive and negative
on first pass culture. A second passage culture was performed for these
samples and results were recalculated.

Bio-Rad
Laboratories

Clinical
Diagnostics Group

For further information, please contact the Bio-Rad office nearest

you or visit our website at www.bio-rad.com/diagnostics.

Website www.bio-rad.com/diagnostics U.S. 1-800-2-BIO-RAD Australia 61-2-9914-2800 Austria 43-1-877-8901 Belgium 32-9-385-5511 Brazil 5521-3461-5202 Canada 1-514-3344372 Czech Republic 420-2-41430532 China 86-21-63052255 Denmark 45-4452-1000 Finland 358-9-804-22-00 France 33-1-4795-6000 Germany 49-89-31884-0 Hong Kong
852-2789-3300 India 91-124-6398112 Israel 972-3-9514127 Italy 39-02-216091 Japan 81-3-5811-6290 Korea 82-2-3473-4460 Latin America 305-894-5950 Mexico 5255-5534-2552
The Netherlands 31-318-540666 New Zealand 64-9-415-2280 Norway 47-23-38-41-30 Poland 48-22-3319999 Portugal 351-21-472-7700 Russia 7-095-721-14-00 Singapore 656415-3188 South Africa 27-11-442-85-08 Spain 34-91-590-5200 Sweden 46-8-555-127-00 Switzerland 41-61-717-95-55 Thailand 662-651-8311 United Kingdom 44-208-328-2000
02/05 DG05-044 J-104

<